MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Parkinson’s disease and chronic inflammatory demyelinating polyneuropathy with celiac disease: Improvement in neuropathy but not Parkinson’s symptoms after intravenous immunoglobulin and gluten free diet

M. Pullman, T. Brannagan, R. Saunders-Pullman (New York, NY, USA)

Meeting: MDS Virtual Congress 2020

Abstract Number: 824

Keywords: Electromyogram(EMG), Immunosuppression, Peripheral neuropathy

Category: Parkinson's Disease: Pathophysiology

Objective: To report a case of celiac disease in Parkinson’s disease and CIPD, and examine the relationship.

Background: Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) is a chronic, symmetric sensorimotor neuropathy, thought to involve immune mediated insult to the myelin sheath, and may be associated with infection, malignancy, and autoimmunity. Parkinson’s disease (PD) has been theorized to involve autoimmune etiologies as well; recent studies have pointed to common genetic pathways between PD and autoimmune diseases including not only Crohn’s Disease, ulcerative colitis and rheumatoid arthritis, but also Celiac’s Disease.

Method: Case study of a 69 year old man with history of undifferentiated connective tissue disease diagnosed at age 51 (clinical dermatomyositis with positive antinuclear antibody and anti-Smith antibody) and onset of gait predominant Parkinson’s disease at age 67. PD onset was characterized by shuffling gait and handwriting difficulties and responded to low dose levodopa therapy.

Results: Two years after onset of PD, there was progressive bilateral leg weakness, imbalance and parasthesias. EMG was suggestive of CIDP, and IVIG led to symptomatic improvement. Evaluation demonstrated elevated gliadin and tissue transglutaminase antibodies; jejunal biopsy confirmed celiac disease. Gluten-free diet normalized his celiac antibody levels. He achieved near total remission (residual mild distal numbness) after tapering off IVIG and continuing a gluten-free diet. His PD symptoms remained stable on carbidopa-levodopa and rasagiline, with slow progression and development of dyskinesias.

Conclusion: We present a case of Parkinson’s disease and multiple autoimmune disorders who developed CIDP, likely secondary to celiac’s disease, which resolved with IVIG and strict gluten-free diet. This case highlights the possible role of auto- or dysimmunity in the pathogenesis of PD, although also suggests that immune-targeted treatment may not affect PD symptoms or progression.

To cite this abstract in AMA style:

M. Pullman, T. Brannagan, R. Saunders-Pullman. Parkinson’s disease and chronic inflammatory demyelinating polyneuropathy with celiac disease: Improvement in neuropathy but not Parkinson’s symptoms after intravenous immunoglobulin and gluten free diet [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/parkinsons-disease-and-chronic-inflammatory-demyelinating-polyneuropathy-with-celiac-disease-improvement-in-neuropathy-but-not-parkinsons-symptoms-after-intravenous-immunoglobulin-and-gluten-free/. Accessed November 11, 2026.
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/parkinsons-disease-and-chronic-inflammatory-demyelinating-polyneuropathy-with-celiac-disease-improvement-in-neuropathy-but-not-parkinsons-symptoms-after-intravenous-immunoglobulin-and-gluten-free/

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley